Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive value creation for our portfolio companies. We invest in the most promising drug discovery companies with the potential to create multiple medicines. Our portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds.
Looking for a particular Nextech Invest employee's phone or email?
The Nextech Invest annual revenue was $6.3 million in 2026.
Thilo Schroeder is the Managing Partner of Nextech Invest.
13 people are employed at Nextech Invest.
Nextech Invest is based in Zürich, Zurich.
The NAICS codes for Nextech Invest are [523, 52, 5239].
The SIC codes for Nextech Invest are [679, 67].